Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-09 Collins Cynthia CEO Sale −1,262 $66.65 $84K 43,760
2020-08-20 Collins Cynthia CEO Sale −1,976 $36.66 $72K 45,022
2020-02-06 Collins Cynthia CEO Grant or award +15,625 46,998
2020-02-06 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +93,750 93,750
2019-09-11 Collins Cynthia CEO Grant or award +20,000 31,373
2019-09-11 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +500,000 500,000
2019-09-11 Collins Cynthia CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2019-08-19 Collins Cynthia CEO Grant or award +8,283 16,566
2019-08-19 Collins Cynthia CEO Sale −5,193 $25.83 $134K 11,373
2019-08-06 Collins Cynthia CEO Grant or award +8,283 16,566
2019-06-12 Collins Cynthia Interim CEO Grant or award · Stock Option (right to buy) +11,538 11,538
2019-01-31 Collins Cynthia Director Grant or award · Restricted Stock Units +8,283 8,283
2018-12-06 Collins Cynthia Director Grant or award · Stock Option (right to buy) +23,076 23,076

Page 1 of 1 · 13 trades